Menopause : a comprehensive approach /
Saved in:
Imprint: | Cham : Springer, 2017. |
---|---|
Description: | 1 online resource (337 pages) |
Language: | English |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11389009 |
Table of Contents:
- Preface
- Contents
- Part I: Biological Background
- 1: Menopause, A Stage in the Life of Women
- References
- 2: Menopause: The Concepts and the Biological Background
- 2.1 Menopause and the Menopause Transition
- 2.2 Epidemiological Data
- 2.3 The Menstrual Cycle During Perimenopause
- 2.4 Variables Affecting Menopause Age
- 2.4.1 Genetics
- 2.4.2 Lifestyle
- 2.4.3 Other Factors
- 2.5 The Biological Basis of Menopause
- 2.5.1 Subclinical Phase
- 2.5.2 Cycle Irregularity
- 2.5.3 Postmenopause
- References
- 3: Primary Ovarian Insufficiency3.1 Introduction
- 3.2 Pathogenesis of POI
- 3.2.1 Genetic Causes
- 3.2.1.1 Non-Syndromic POI
- Ligands of the TGF-Beta Family
- BMP-15
- GDF-9
- Inhibin AÂ (INHA)
- FMR1
- G-Protein-Coupled Receptors
- SF-1 (NR5A1)
- Other Transcription Factors
- FOXO3a
- NOBOX
- FIGLA
- 3.2.1.2 Syndromic POI
- Turner Syndrome
- Congenital Disorder of Glycosylation [Carbohydrate-Deficient Glycoprotein Syndrome (CDGs) Syndrome] and Galactosemia
- Pseudohypoparathyroidism Type 1a (PHP1A)
- Autoimmune Polyglandular Syndrome Type 1Progressive External Ophthalmoplegia
- Ovarioleukodystrophy
- Ataxia Telangiectasia
- Demirhan Syndrome
- Blepharophimosis, Ptosis, Epicanthus Inversus Syndrome (BPES)
- 3.2.2 Autoimmune Causes of POI
- 3.2.3 Metabolic Disorders
- 3.2.4 Infectious Causes
- 3.2.5 Iatrogenic Causes
- 3.3 Epidemiology
- 3.4 Definition and Clinical Presentation
- 3.4.1 Definition
- 3.4.2 Clinical Presentation
- 3.4.3 Personal and Family History
- 3.4.4 Physical Examination
- 3.4.5 Initial Laboratory Assessment3.4.6 Further Investigation
- 3.4.6.1 Genetic
- 3.4.6.2 Autoimmune
- Anti-ovarian Antibodies
- Lymphocytic Oophoritis
- Association with Other Autoimmune Disorders
- 3.4.7 Risk Assessment for Premature Ovarian Senescence
- 3.4.7.1 Pelvic Ultrasonography and Ovarian Biopsy
- 3.4.7.2 AMH and Inhibin B
- 3.5 Long-Term Consequences and Follow-Up
- 3.5.1 Bone Health
- 3.5.2 Cardiovascular Disease
- 3.5.3 Psychological Aspects
- 3.5.4 Mortality
- 3.6 Management
- 3.6.1 Hormonal Therapy
- 3.6.1.1 Hormonal Supplementation in Postpubertal POI Patients3.6.1.2 Puberty Induction
- 3.6.1.3 Nonhormonal Therapies
- 3.6.2 The Management of Patients with Turner Syndrome
- 3.6.3 Surveillance of Cancer Survivors
- 3.6.4 Supportive Management
- 3.6.5 Reproductive Issues
- 3.6.5.1 Resumption of Ovarian Function and Spontaneous Pregnancy Rate
- 3.6.5.2 Fertility, Pregnancy, Pregnancy Outcome
- 3.6.5.3 Obstetric Risks Associated with POI
- Turner Syndrome and Pregnancy
- 3.6.6 Oncofertility
- 3.6.6.1 Fertility-Sparing Surgery